tradmap

IMDX Earnings Insight Molecular Diagnostics Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$13 -$7 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $2M $4M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$73M -$36M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$5 -$2 $0 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $1M $2M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$34M -$17M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–18 of 18
Q2 20262026-06-30-0.442026-08-1010-Q
Q1 20262026-03-31-0.122026-05-1310-Q
FY 20252025-12-31-1.652026-03-2610-K
Q3 20252025-09-30-0.912025-11-1010-Q
Q2 20262025-06-30-0.572026-08-1010-Q
Q1 20262025-03-31-0.262026-05-1310-Q
FY 20252024-12-31-4.662026-03-2610-K
Q3 20252024-09-30-2.362025-11-1010-Q
Q2 20252024-06-30-1.322025-08-1110-Q
Q1 20252024-03-31-1.132025-05-1210-Q
FY 20242023-12-31-3.752025-03-2410-K
Q3 20242023-09-30-1.682024-11-1210-Q
Q2 20242023-06-30-0.832024-08-0810-Q
Q1 20242023-03-310.402024-05-1510-Q
FY 20232022-12-31-13.252024-04-1610-K
Q3 20232022-09-30-5.222023-11-0910-Q
Q2 20232022-06-30-3.632023-08-1010-Q
Q1 20232022-03-31-0.112023-05-1510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.